| News
Leading startups benefit from BaselArea.swiss
05.09.2019
The top 100 startups of Switzerland have been revealed. In Venturelab’s Top 100, the Basel region performs particularly well in the biotech sector, while almost all the Basel companies named have benefited directly or indirectly from BaselArea.swiss.

time for startup (img: Tashatuvango/shutterstock)
Seven companies from the canton of Basel-Stadt and two from the canton of Basel-Landschaft qualified for the Top 100 of Swiss startups. Now, Venturelab has published its latest ranking. Five biotech startups made it into the top 20 – and two of them are from Basel.
Polyneuron Pharmaceuticals AG (14th place) received support from the healthcare accelerator BaseLaunch, which is operated by BaselArea.swiss. The location promotion organization also directly provided services to Cellestia Biotech AG (19th place). With T3 Pharmaceuticals (24th place) and Anaveon AG (37th place) from Bottmingen BL, two other Basel companies supported by BaseLaunch made it into the top 40.
In this year’s top 40 Swiss startups are MaxWell Biosystems (33rd place) and Artidis (36th place). Alongside medtech company Resistell (34th place) from Muttenz BL, they too benefited from BaselArea.swiss. The same goes for the micro- and nanotechnology company Qnami (64th place) from Basel. Internet and mobile company MyCamper (87th place) rounds off the Basel region’s companies in the top 100.
The list is topped by four companies in the electronics/mechanics and medtech sectors. In first place is Lausanne drone provider Flyability, followed by medtech company Lunaphore, which also hails from Lausanne. Two German-Swiss companies are in places 3 and 4 – the Zurich medtech company Ava and flight devices provider Wingtra from Zug. The best biotech company in the ranking is Cutiss AG from Zurich in 6th place.
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Clinerion is now part of Citeline
Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...
Read MoreKUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read MoreBSI integrating AI from Parashift in banking software
Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...
Read MoreUptownBasel joins IBM Quantum Network
UptownBasel is partnering with IBM. The emerging competence center for Industry 4.0 will provide its partners with the IBM Quantum...
Read MoreSouth Korean pharma firms show interest in the Basel Area
Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...
Read More